Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 4
2006 2
2007 4
2008 5
2009 6
2010 6
2011 3
2012 1
2013 2
2015 3
2016 4
2017 4
2018 1
2019 3
2020 3
2021 5
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.
González-López TJ, Provan D, Bárez A, Bernardo-Gutiérrez A, Bernat S, Martínez-Carballeira D, Jarque-Ramos I, Soto I, Jiménez-Bárcenas R, Fernández-Fuertes F. González-López TJ, et al. Among authors: provan d. Blood Rev. 2023 Sep;61:101112. doi: 10.1016/j.blre.2023.101112. Epub 2023 Jun 29. Blood Rev. 2023. PMID: 37414719 Review.
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Rodeghiero F, et al. Among authors: provan d. Blood. 2009 Mar 12;113(11):2386-93. doi: 10.1182/blood-2008-07-162503. Epub 2008 Nov 12. Blood. 2009. PMID: 19005182 Free article.
International consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. Provan D, et al. Blood. 2010 Jan 14;115(2):168-86. doi: 10.1182/blood-2009-06-225565. Epub 2009 Oct 21. Blood. 2010. PMID: 19846889 Free article. Review.
The diagnosis and management of primary autoimmune haemolytic anaemia.
Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A; British Society for Haematology. Hill QA, et al. Among authors: provan d. Br J Haematol. 2017 Feb;176(3):395-411. doi: 10.1111/bjh.14478. Epub 2016 Dec 22. Br J Haematol. 2017. PMID: 28005293 Free article. No abstract available.
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB. Cooper N, et al. Among authors: provan d. Am J Hematol. 2021 Feb 1;96(2):199-207. doi: 10.1002/ajh.26036. Epub 2020 Dec 19. Am J Hematol. 2021. PMID: 33107998 Free PMC article.
Investigational drugs for immune thrombocytopenia.
Provan D, Newland AC. Provan D, et al. Expert Opin Investig Drugs. 2022 Jul;31(7):715-727. doi: 10.1080/13543784.2022.2075340. Epub 2022 May 11. Expert Opin Investig Drugs. 2022. PMID: 35531637
70 results